Neuromed IRCCS clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.
-
Minor: 2 trials marked Unknown by the registry's verification sweep Changed
- Minor: Transcranial Static Magnetic Field Stimulation (tSMS) in Progressive Multiple Sclerosis Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: Psychometric Evaluation · Brain Damage During Neuroinflammation Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Enrolling by Invitation
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-10 | NCT07928453 Cardiovascular And Dementia Risk in diabeTes: the Role of Nox2- Related Oxidative Stress. | Recruiting | |
| 2026-11-04 | NCT07917546 Early COMT Inhibition in PD | Completed |
Active trials by phase
Not charted: 9 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Dementia (6) · Alzheimer's Disease (4) · Parkinson's Disease (3) · ALS (2) · Diabetes (2) · Epilepsy (1) · Huntington's Disease (1) · Multiple Sclerosis (1) · Type 2 Diabetes (1)
Get alerts when Neuromed IRCCS's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.